Large population-based study of first trimester tetracycline use and major congenital malformation risks

A collaborative of researchers from Karolinska Institutet (Stockholm, Sweden), Norwegian Institute of Public Health (Oslo, Norway) and Statens Serum Institut (Copenhagen, Denmark), have published a large population-based study using Swedish healthcare system datasets to investigate the association between first trimester exposure to tetracyclines and major congenital malformation risks. More information is available here.

Photo by Kamal Hoseinianzade on Unsplash